Literature DB >> 20870401

Plasma F2-isoprostane level and cognitive function over eight years in non-demented older adults: Findings from the Health ABC Study.

A J Fiocco1, A M Kanaya, K M Lindquist, T B Harris, S Satterfield, E M Simonsick, L Kuller, C Rosano, K Yaffe.   

Abstract

F2-isoprostanes (F2-IsoP) are reportedly increased in dementia patients, and are considered a reliable biomarker of oxidation. However, few studies have examined the predictive value of peripheral F2-IsoP levels in non-demented older adults. This study assesses the association between plasma F2-IsoP and change in cognitive function in non-demented elderly over eight years. Plasma F2-IsoP was measured by gas chromatography-mass spectrometry in a biracial cohort of 726 elderly men and women. Digit Symbol Substitution test and the Modified Mini-Mental State Exam were administered over time. No association was found between F2-IsoP tertile and baseline or change (slope) in cognitive function over eight years. Plasma F2-IsoP is not a valuable biomarker in predicting cognitive change over years in non-demented older adults. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20870401      PMCID： PMC3015004          DOI： 10.1016/j.plefa.2010.09.001

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN： 0952-3278            Impact factor:   4.006


  31 in total

1.  Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer's disease.

Authors:  E E Tuppo; L J Forman; B W Spur; R E Chan-Ting; A Chopra; T A Cavalieri
Journal:  Brain Res Bull       Date:  2001-03-15       Impact factor: 4.077

2.  Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity.

Authors:  D Praticò; C M Clark; V M Lee; J Q Trojanowski; J Rokach; G A FitzGerald
Journal:  Ann Neurol       Date:  2000-11       Impact factor: 10.422

3.  Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels.

Authors:  David Reich; Nick Patterson; Vijaya Ramesh; Philip L De Jager; Gavin J McDonald; Arti Tandon; Edwin Choy; Donglei Hu; Bani Tamraz; Ludmila Pawlikowska; Christina Wassel-Fyr; Scott Huntsman; Alicja Waliszewska; Elizabeth Rossin; Rongling Li; Melissa Garcia; Alexander Reiner; Robert Ferrell; Steve Cummings; Pui-Yan Kwok; Tamara Harris; Joseph M Zmuda; Elad Ziv
Journal:  Am J Hum Genet       Date:  2007-03-08       Impact factor: 11.025

4.  Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosis.

Authors:  M S Forman; E J Mufson; S Leurgans; D Pratico; S Joyce; S Leight; V M-Y Lee; J Q Trojanowski
Journal:  Neurology       Date:  2007-03-06       Impact factor: 9.910

5.  Determination of isoprostanes in urine samples from Alzheimer patients using porous graphitic carbon liquid chromatography-tandem mass spectrometry.

Authors:  Kristina Claeson Bohnstedt; Bo Karlberg; Lars-Olof Wahlund; Maria Eriksdotter Jönhagen; Hans Basun; Staffan Schmidt
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-10-25       Impact factor: 3.205

6.  Dietary antioxidant supplementation reverses age-related neuronal changes.

Authors:  E O'Donnell; M A Lynch
Journal:  Neurobiol Aging       Date:  1998 Sep-Oct       Impact factor: 4.673

Review 7.  Oxidative stress and transcriptional regulation in Alzheimer disease.

Authors:  Qingli Shi; Gary E Gibson
Journal:  Alzheimer Dis Assoc Disord       Date:  2007 Oct-Dec       Impact factor: 2.703

8.  Studies on lipid peroxidation and protein oxidation in the aging brain.

Authors:  M Cini; A Moretti
Journal:  Neurobiol Aging       Date:  1995 Jan-Feb       Impact factor: 4.673

9.  Folstein vs modified Mini-Mental State Examination in geriatric stroke. Stability, validity, and screening utility.

Authors:  J Grace; J D Nadler; D A White; T J Guilmette; A J Giuliano; A U Monsch; M G Snow
Journal:  Arch Neurol       Date:  1995-05

10.  Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress.

Authors:  J D Morrow; L J Roberts
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600
View more
  3 in total

1.  African Ancestry Gradient Is Associated with Lower Systemic F2-Isoprostane Levels.

Authors:  Francis Annor; Michael Goodman; Bharat Thyagarajan; Ike Okosun; Ayo Doumatey; Barbara A Gower; Dora Il'yasova
Journal:  Oxid Med Cell Longev       Date:  2017-01-31       Impact factor: 6.543

2.  CoQ10 and Cognition a Review and Study Protocol for a 90-Day Randomized Controlled Trial Investigating the Cognitive Effects of Ubiquinol in the Healthy Elderly.

Authors:  Con Stough; Madeleine Nankivell; David A Camfield; Naomi L Perry; Andrew Pipingas; Helen Macpherson; Keith Wesnes; Ruchong Ou; David Hare; Judy de Haan; Geoffrey Head; Peter Lansjoen; Alena Langsjoen; Brendan Tan; Matthew P Pase; Rebecca King; Renee Rowsell; Oliver Zwalf; Yossi Rathner; Matthew Cooke; Franklin Rosenfeldt
Journal:  Front Aging Neurosci       Date:  2019-05-29       Impact factor: 5.750

Review 3.  Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer's disease.

Authors:  Gary P Morris; Ian A Clark; Bryce Vissel
Journal:  Acta Neuropathol       Date:  2018-10-22       Impact factor: 17.088
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.